C-Arm X-Ray Machine Guided Blocking Treatment of Lumbar Facet Joint Osteoarthritis

2013 ◽  
Vol 756-759 ◽  
pp. 4549-4552
Author(s):  
Liang Li ◽  
Li Heng Zhang ◽  
Yue Zhou
Keyword(s):  
Facet Joint ◽  
Effective Rate ◽  
Term Treatment ◽  
Lumbar Facet Joint ◽  
X Ray ◽  
Facet Joint Osteoarthritis ◽  
Long Term Treatment ◽  
Long Acting ◽  
Lumbar Facet

Our objective is to find a more exact treatment program in long-term treatment of lumbar facet osteoarthritis. We adopted a long-acting local anesthetic, hormone dubbed blocking solution, treated 34 patients suffered from lumbar facet joint osteoarthritis by blocking under C-arm X-ray machine perspective guidance. It was found that the puncture success rate reached 100%. The effective rate is (31/34) 91.2%. Followed-up for more than six months, 3 cases in 31 cases recured, and the recurrence rate was 3.2%. Complications of this method were only 2.94%. C-arm X-ray machine guided blocking treatment of lumbar facet joint osteoarthritis is economic, practical, conveniently operating and effective. It is an ideal treatment option for the treatment of lumbar facet joint osteoarthritis.

Sustained drug delivery optimizes long-term treatment of patients with schizophrenia

2004 ◽  
Vol 16 (6) ◽  
pp. 319-325 ◽  
Author(s):  
Pierre S. Chue ◽  
Peter D'Hoore ◽  
J. Michael Ramstack
Keyword(s):  
Antipsychotic Agents ◽  
Term Treatment ◽  
Treatment Programs ◽  
Sustained Drug Delivery ◽  
Partial Compliance ◽  
Long Term Treatment ◽  
Optimal Maintenance ◽  
Long Acting ◽  
The Impact

Chronic disorders such as schizophrenia require long-term treatment programs in order to maintain patients at the lowest level of symptomatology, reduce the likelihood of psychotic relapse, and support achievement of remission and recovery. Evidence suggests that treatment with long-acting injectable antipsychotics reduces the impact of partial compliance and provides predictable release of medication, assuring continuous therapeutic coverage. Until recently, only conventional antipsychotic agents were available in long-acting formulations, thereby foregoing the advantages of the atypical class. Atypical agents which are given orally have been shown to provide long-term efficacy and tolerability benefits compared with conventional agents, but are limited by the need for daily administration. The most recent pharmacological strategy to achieve optimal maintenance treatment has been to combine the benefits of an atypical antipsychotic with delivery in a water-based long-acting formulation. The first antipsychotic to achieve this combination – long-acting risperidone – may thus represent an important advance in the optimization of long-term treatment outcomes in patients with schizophrenia.

scholarly journals Distribution of strontium and mineralization in iliac bone biopsies from osteoporotic women treated long-term with strontium ranelate

2011 ◽  
Vol 165 (3) ◽  
pp. 469-476 ◽  
Author(s):  
Audrey Doublier ◽  
Delphine Farlay ◽  
Mohamed T Khebbab ◽  
Xavier Jaurand ◽  
Pierre J Meunier ◽  
...  
Keyword(s):  
Bone Mineralization ◽  
Progressive Increase ◽  
Tissue Level ◽  
Term Treatment ◽  
Iliac Bone ◽  
X Ray ◽  
Long Term Treatment ◽  
Bone Biopsies

ObjectiveTo investigate interactions between strontium (Sr) and bone mineral and its effects on mineralization in osteoporotic women treated long-term with Sr ranelate (SrRan).DesignIn this study, 34 iliac bone biopsies were analyzed after 2, 12, 24, 36, 48, and 60 months of treatment with SrRan.MethodsSr global distribution was analyzed by X-ray cartography and the percentage of bone area containing Sr was calculated in the bone samples. The focal distribution of Sr in all bone samples was investigated by X-ray microanalysis. The degree of mineralization was assessed by quantitative microradiography.ResultsAbsent from old bone formed before the beginning of treatment, Sr was exclusively present in bone formed during this treatment with a much higher focal Sr content in new bone structural units than in old ones. A progressive increase in the extent of areas containing Sr was observed during treatment. The focal bone Sr content in recently formed bone was constant over treatment. Secondary mineralization was maintained at a normal level during treatment.ConclusionThus, the quality of bone mineralization (density and heterogeneity at tissue level) was preserved after a long-term treatment with SrRan.

scholarly journals THU0432 LUMBAR FACET JOINT OSTEOARTHRITIS IS A RISK FACTOR OF SACROILIAC JOINTS DEGENERATION

2019 ◽  
Author(s):  
Zhi-xiang Huang ◽  
LI Guo-Chao ◽  
Qi MI ◽  
Shi-Yu Wang ◽  
Wei-Ming Deng ◽  
...  
Keyword(s):  
Risk Factor ◽  
Facet Joint ◽  
Sacroiliac Joints ◽  
Lumbar Facet Joint ◽  
Facet Joint Osteoarthritis ◽  
Lumbar Facet

Long-term treatment of refractory neonatal hypoglycemia with long-acting somatostatin analog

1987 ◽  
Vol 111 (4) ◽  
pp. 548-551 ◽  
Author(s):  
Jeffrey A. Jackson ◽  
Henry B. Hahn ◽  
Charles E. Oltorf ◽  
Thomas M. O'Dorisio ◽  
Arthur I. Vinik
Keyword(s):  
Term Treatment ◽  
Somatostatin Analog ◽  
Neonatal Hypoglycemia ◽  
Long Term Treatment ◽  
Long Acting

The Role of Long Acting Antipsychotics in Bipolar Disorder

2017 ◽  
Vol 41 (S1) ◽  
pp. S15-S15
Author(s):  
E. Vieta
Keyword(s):  
Bipolar Disorder ◽  
Meta Analysis ◽  
Term Treatment ◽  
Patient Profile ◽  
Long Term Treatment ◽  
Short And Long Term ◽  
Competing Interest ◽  
Long Acting

Antipsychotics are widely used for the short and long-term treatment of bipolar disorder. Depot and long-acting injectable formulations (LAIs) can be particularly useful for certain subgroups of patients. This lecture will discuss the available data from randomized controlled trials of LAIs in bipolar disorder. A recently published meta-analysis and individual studies assessing depot medications, as well as modern LAIs such as risperidone, paliperidone and aripiprazole, will be reviewed, looking carefully into the prevention of either pole of illness and tolerability. Potential indications and patient profile, based on data and clinical experience, will be discussed.Disclosure of interestThe author has not supplied his declaration of competing interest.

scholarly journals LONG TERM TREATMENT BY A LONG ACTING SOMATOSTATIN ANALOGUE (SMS 201–995) IN A 4 MONTHS BOY PRESENTING WITH PRIMARY PERMANENT HYPERINSULINISM

1988 ◽  
Vol 23 (1) ◽  
pp. 135-135 ◽  
Author(s):  
M T Tauber ◽  
J P Tauber ◽  
A G Harris ◽  
J M Lafitte ◽  
M Keddari ◽  
...  
Keyword(s):  
Term Treatment ◽  
Somatostatin Analogue ◽  
Long Term Treatment ◽  
Long Acting
Sign in / Sign up

Export Citation Format

Share Document